Chromadex Corp. posts $22.56 million revenue in quarter ended Mar 31, 2023
By USInMinutes - May 13, 2023, 11:31 AM ET
Last Updated - Jul 18, 2023, 03:29 PM EDT
Key fundamental financials
loss of $1.90 million
Revenue of $22.56 million
Chromadex Corp. [CDXC] has reported $1.90 million loss for the fiscal quarter ending Mar 31, 2023.
Revenue for the quarter was $22.56 million with operating income of $1.97 million.
The Irvine, California (CA)-based company operating in the medicinal chemicals & botanical products sector has total shareholders equity of $28.02 million.
